SCM
PRCT icon

Sterling Capital Management’s Procept Biorobotics PRCT Stock Holding History

Sterling Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Sell
197
-149
-43% -$3.73K ﹤0.01% 2684
2026
Q1 		$8.65K Sell
346
-3
-0.9% -$85 ﹤0.01% 2454
2025
Q4 		$11K Buy
349
+222
+175% +$7.36K ﹤0.01% 2559
2025
Q3 		$4.53K Hold
127
– – ﹤0.01% 2791
2025
Q2 		$7.32K Buy
127
+81
+176% +$4.58K ﹤0.01% 2305
2025
Q1 		$2.68K Hold
46
– – ﹤0.01% 2473
2024
Q4 		$3.7K Buy
46
+3
+7% +$256 ﹤0.01% 2579
2024
Q3 		$3.44K Buy
+43
New +$3.06K ﹤0.01% 1921

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sterling Capital Management's PRCT Position: Q2 2026 in Review

Sterling Capital Management reduced its Procept Biorobotics (PRCT) stake by 43% in Q2 2026, selling an estimated $3.73K and leaving 197 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Sterling Capital Management first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $11K in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Sterling Capital Management held 197 shares of Procept Biorobotics worth $4.45K as of Q2 2026.
  • Sterling Capital Management sold 149 Procept Biorobotics shares in Q2 2026, an estimated $3.73K.
  • Procept Biorobotics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2684 holding.
  • Sterling Capital Management first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Procept Biorobotics position peaked at $11K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.